Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot study of etanercept treatment for pemphigus vulgaris.
Fiorentino DF, Garcia MS, Rehmus W, Kimball AB. Fiorentino DF, et al. Arch Dermatol. 2011 Jan;147(1):117-8. doi: 10.1001/archdermatol.2010.409. Arch Dermatol. 2011. PMID: 21242406 Clinical Trial. No abstract available.
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study.
Strand V, Fiorentino D, Hu C, Day RM, Stevens RM, Papp KA. Strand V, et al. Among authors: fiorentino d. Health Qual Life Outcomes. 2013 May 10;11:82. doi: 10.1186/1477-7525-11-82. Health Qual Life Outcomes. 2013. PMID: 23663752 Free PMC article. Clinical Trial.
Localized cutaneous fibrosing disorders.
Yaqub A, Chung L, Rieger KE, Fiorentino DF. Yaqub A, et al. Rheum Dis Clin North Am. 2013 May;39(2):347-64. doi: 10.1016/j.rdc.2013.02.013. Epub 2013 Mar 16. Rheum Dis Clin North Am. 2013. PMID: 23597968 Review.
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. Aggarwal R, et al. Among authors: fiorentino d. Ann Rheum Dis. 2017 May;76(5):792-801. doi: 10.1136/annrheumdis-2017-211400. Ann Rheum Dis. 2017. PMID: 28385805 Free PMC article.
Imatinib in the treatment of nephrogenic systemic fibrosis.
Chandran S, Petersen J, Jacobs C, Fiorentino D, Doeden K, Lafayette RA. Chandran S, et al. Among authors: fiorentino d. Am J Kidney Dis. 2009 Jan;53(1):129-32. doi: 10.1053/j.ajkd.2008.08.029. Epub 2008 Nov 13. Am J Kidney Dis. 2009. PMID: 19012999
256 results